Symbols / ICUI Stock $124.82 +0.22% ICU Medical, Inc.

Healthcare • Medical Instruments & Supplies • United States • NMS
ICUI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Vivek Jain
Exch · Country NMS · United States
Market Cap 3.12B
Enterprise Value 4.12B
Income 732.00K
Sales 2.23B
FCF (ttm) 394.96M
Book/sh 86.03
Cash/sh 12.62
Employees 13,000
Insider 10d —
IPO Mar 31, 1992
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 6,241.00
Forward P/E 13.58
PEG 0.07
P/S 1.40
P/B 1.45
P/C —
EV/EBITDA 13.28
EV/Sales 1.85
Quick Ratio 0.99
Current Ratio 2.39
Debt/Eq 63.48
LT Debt/Eq —
EPS (ttm) 0.02
EPS next Y 9.19
EPS Growth —
Revenue Growth -14.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-19
ROA 1.66%
ROE 0.04%
ROIC —
Gross Margin 36.84%
Oper. Margin 4.82%
Profit Margin 0.03%
Shs Outstand 24.99M
Shs Float 24.21M
Insider Own 3.79%
Instit Own 114.68%
Short Float 6.23%
Short Ratio 4.63
Short Interest 1.30M
52W High 160.29
vs 52W High -22.13%
52W Low 107.00
vs 52W Low 16.65%
Beta 0.85
Impl. Vol. 1.41%
Rel Volume 0.75
Avg Volume 286.85K
Volume 213.97K
Target (mean) $180.17
Tgt Median $180.00
Tgt Low $163.00
Tgt High $200.00
# Analysts 6
Recom Buy
Prev Close $124.55
Price $124.82
Change 0.22%
About

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$180.17
Mean price target
2. Current target
$124.82
Latest analyst target
3. DCF / Fair value
$284.46
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$124.82
Low
$163.00
High
$200.00
Mean
$180.17

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-17 main Piper Sandler Overweight → Overweight $163
2026-02-20 main Keybanc Overweight → Overweight $180
2026-02-20 main Piper Sandler Overweight → Overweight $178
2025-11-07 main Keybanc Overweight → Overweight $175
2025-11-07 main Piper Sandler Overweight → Overweight $172
2025-10-21 main Keybanc Overweight → Overweight $173
2025-09-10 main Piper Sandler Overweight → Overweight $153
2025-08-15 init Piper Sandler — → Overweight $145
2025-08-08 main Raymond James Strong Buy → Strong Buy $180
2025-05-09 main Raymond James Strong Buy → Strong Buy $187
2025-04-21 main Keybanc Overweight → Overweight $191
2025-04-08 reit Needham Hold → Hold —
2024-12-11 up Jefferies Hold → Buy $200
2024-11-13 main Keybanc Overweight → Overweight $209
2024-11-13 reit Needham — → Hold —
2024-10-15 main Keybanc Overweight → Overweight $198
2024-10-14 init Jefferies — → Hold $183
2024-10-10 reit Needham — → Hold —
2024-09-12 main Raymond James Outperform → Outperform $190
2024-08-08 main Keybanc Overweight → Overweight $147
News
RSS: Latest ICUI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-13 SANZONE VIRGINIA RUTH General Counsel — 7,324 — —
2026-03-13 VOIGTLANDER CHRISTIAN B Chief Operating Officer — 14,648 — —
2026-03-13 WOOLSON DANIEL Officer — 2,924 — —
2026-03-13 BONNELL BRIAN MICHAEL Chief Financial Officer — 14,648 — —
2026-03-13 SOUSA BEN Chief Technology Officer — 1,300 — —
2026-03-13 JAIN VIVEK Chief Executive Officer — 21,972 — —
2026-03-06 SANZONE VIRGINIA RUTH General Counsel — 29,454 — —
2026-03-06 VOIGTLANDER CHRISTIAN B Chief Operating Officer — 75,279 — —
2026-03-06 WOOLSON DANIEL Officer — 19,885 — —
2026-03-06 BONNELL BRIAN MICHAEL Chief Financial Officer — 75,279 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,231.26
-6.33%
2,382.05
+5.44%
2,259.13
-0.92%
2,280.00
Operating Revenue
2,231.26
-6.33%
2,382.05
+5.44%
2,259.13
-0.92%
2,280.00
Cost Of Revenue
1,409.22
-9.51%
1,557.26
+2.50%
1,519.25
-3.98%
1,582.24
Reconciled Cost Of Revenue
1,409.22
-9.51%
1,557.26
+2.50%
1,519.25
-3.98%
1,582.24
Gross Profit
822.04
-0.33%
824.78
+11.48%
739.87
+6.04%
697.76
Operating Expense
712.71
-2.02%
727.38
+5.11%
692.04
-1.32%
701.33
Research And Development
87.50
-1.26%
88.61
+3.83%
85.34
-8.22%
92.98
Selling General And Administration
625.21
-2.12%
638.76
+5.29%
606.69
-0.27%
608.35
Other Operating Expenses
—
—
—
—
Total Expenses
2,121.93
-7.12%
2,284.64
+3.32%
2,211.29
-3.17%
2,283.57
Operating Income
109.33
+12.25%
97.41
+103.62%
47.84
+1440.70%
-3.57
Total Operating Income As Reported
42.83
-0.31%
42.96
+88.23%
22.82
+153.21%
-42.90
EBITDA
298.44
+14.77%
260.04
+2.70%
253.20
+32.19%
191.55
Normalized EBITDA
320.73
-1.58%
325.88
+14.63%
284.28
+18.84%
239.21
Reconciled Depreciation
200.74
-8.55%
219.51
-4.05%
228.77
-2.71%
235.15
EBIT
97.70
+141.05%
40.53
+65.91%
24.43
+156.02%
-43.60
Total Unusual Items
-22.29
+66.14%
-65.84
-111.83%
-31.08
+34.79%
-47.66
Total Unusual Items Excluding Goodwill
-22.29
+66.14%
-65.84
-111.83%
-31.08
+34.79%
-47.66
Special Income Charges
-26.08
+53.47%
-56.05
-122.73%
-25.16
+39.92%
-41.88
Restructuring And Mergern Acquisition
66.50
+22.16%
54.44
+117.67%
25.01
-36.41%
39.33
Net Income
0.73
+100.62%
-117.69
-296.86%
-29.66
+60.08%
-74.29
Pretax Income
4.36
+106.60%
-66.01
+15.69%
-78.30
+31.56%
-114.41
Net Non Operating Interest Income Expense
-83.03
+13.29%
-95.75
-0.56%
-95.22
-43.46%
-66.38
Interest Expense Non Operating
93.34
-12.39%
106.54
+3.71%
102.73
+45.08%
70.81
Net Interest Income
-83.03
+13.29%
-95.75
-0.56%
-95.22
-43.46%
-66.38
Interest Expense
93.34
-12.39%
106.54
+3.71%
102.73
+45.08%
70.81
Interest Income Non Operating
10.31
-4.46%
10.79
+43.69%
7.51
+69.48%
4.43
Interest Income
10.31
-4.46%
10.79
+43.69%
7.51
+69.48%
4.43
Other Income Expense
-21.95
+67.57%
-67.66
-118.86%
-30.92
+30.47%
-44.47
Other Non Operating Income Expenses
0.35
+119.09%
-1.82
-1198.19%
0.17
-94.81%
3.20
Gain On Sale Of Security
3.79
+138.66%
-9.79
-65.46%
-5.92
-2.39%
-5.78
Gain On Sale Of Business
44.79
0.00
0.00
—
Tax Provision
2.44
-95.28%
51.68
+206.23%
-48.64
-21.24%
-40.12
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
-40.17%
0.00
Tax Effect Of Unusual Items
-4.68
+66.14%
-13.83
-111.83%
-6.53
+60.99%
-16.73
Net Income Including Noncontrolling Interests
0.73
+100.62%
-117.69
-296.86%
-29.66
+60.08%
-74.29
Net Income From Continuing Operation Net Minority Interest
0.73
+100.62%
-117.69
-296.86%
-29.66
+60.08%
-74.29
Net Income From Continuing And Discontinued Operation
0.73
+100.62%
-117.69
-296.86%
-29.66
+60.08%
-74.29
Net Income Continuous Operations
0.73
+100.62%
-117.69
-296.86%
-29.66
+60.08%
-74.29
Normalized Income
18.34
+127.93%
-65.67
-1187.66%
-5.10
+88.24%
-43.35
Net Income Common Stockholders
0.73
+100.62%
-117.69
-296.86%
-29.66
+60.08%
-74.29
Diluted EPS
0.03
+100.62%
-4.83
-292.68%
-1.23
+60.45%
-3.11
Basic EPS
0.03
+100.62%
-4.83
-292.68%
-1.23
+60.45%
-3.11
Basic Average Shares
24.64
+1.03%
24.39
+1.23%
24.09
+0.93%
23.87
Diluted Average Shares
24.90
+2.12%
24.39
+1.23%
24.09
+0.93%
23.87
Diluted NI Availto Com Stockholders
0.73
+100.62%
-117.69
-296.86%
-29.66
+60.08%
-74.29
Earnings From Equity Interest Net Of Tax
-1.19
0.00
0.00
—
Gain On Sale Of PPE
-4.37
-171.52%
-1.61
-950.98%
-0.15
+94.01%
-2.55
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
4,050.51
-3.65%
4,203.93
-3.99%
4,378.44
-3.04%
4,515.64
Current Assets
1,190.55
-17.44%
1,441.98
+18.07%
1,221.27
-1.13%
1,235.20
Cash Cash Equivalents And Short Term Investments
307.96
-0.20%
308.57
+21.14%
254.72
+19.58%
213.01
Cash And Cash Equivalents
307.96
-0.20%
308.57
+21.38%
254.22
+21.76%
208.78
Other Short Term Investments
—
0.00
-100.00%
0.50
-88.14%
4.22
Receivables
203.91
+1.88%
200.14
+9.88%
182.15
-26.23%
246.90
Accounts Receivable
180.51
-1.27%
182.83
+13.16%
161.57
-27.13%
221.72
Gross Accounts Receivable
194.90
-0.46%
195.81
+13.42%
172.63
-25.02%
230.25
Allowance For Doubtful Accounts Receivable
-14.38
-10.83%
-12.98
-17.29%
-11.06
-29.71%
-8.53
Other Receivables
23.39
+35.11%
17.31
-2.92%
17.83
-17.57%
21.64
Taxes Receivable
—
4.45
+61.75%
2.75
-22.50%
3.55
Inventory
615.86
+5.33%
584.68
-17.58%
709.36
+1.92%
696.01
Raw Materials
265.38
+0.04%
265.27
-10.39%
296.04
+3.16%
286.96
Work In Process
38.10
+1.52%
37.53
-36.29%
58.91
-20.18%
73.80
Finished Goods
312.38
+10.82%
281.87
-20.47%
354.42
+5.72%
335.25
Prepaid Assets
25.47
+18.32%
21.53
-36.75%
34.03
-6.06%
36.23
Current Deferred Assets
13.11
+44.70%
9.06
+20.96%
7.49
+20.32%
6.22
Assets Held For Sale Current
0.00
-100.00%
284.38
0.00
—
Hedging Assets Current
3.75
-66.07%
11.04
-63.02%
29.85
-10.34%
33.29
Other Current Assets
20.50
-9.26%
22.59
+516.12%
3.67
+3.82%
3.53
Total Non Current Assets
2,859.95
+3.55%
2,761.95
-12.52%
3,157.17
-3.76%
3,280.45
Net PPE
511.89
+2.52%
499.30
-27.17%
685.52
-3.93%
713.58
Gross PPE
1,157.80
+6.01%
1,092.20
-16.59%
1,309.41
+5.60%
1,240.02
Accumulated Depreciation
-645.91
-8.94%
-592.90
+4.97%
-623.89
-18.51%
-526.44
Properties
176.97
-0.07%
177.09
-36.36%
278.25
+1.53%
274.06
Machinery Furniture Equipment
574.27
+4.24%
550.94
-13.39%
636.08
+13.61%
559.90
Construction In Progress
90.75
+4.30%
87.01
-25.77%
117.22
-23.34%
152.91
Other Properties
315.81
+13.94%
277.16
-0.25%
277.86
+9.76%
253.15
Goodwill And Other Intangible Assets
2,133.31
-1.85%
2,173.56
-7.23%
2,343.03
-3.66%
2,432.02
Goodwill
1,499.75
+4.67%
1,432.77
-2.69%
1,472.45
+1.60%
1,449.26
Other Intangible Assets
633.56
-14.48%
740.79
-14.91%
870.59
-11.41%
982.77
Investments And Advances
131.59
+4231.34%
3.04
-2.63%
3.12
-15.54%
3.69
Long Term Equity Investment
131.59
+4231.34%
3.04
-2.63%
3.12
-1.83%
3.18
Non Current Accounts Receivable
—
23.63
-22.84%
30.63
+13.07%
27.09
Non Current Deferred Assets
25.89
+6.94%
24.21
-40.56%
40.73
+11.23%
36.62
Non Current Deferred Taxes Assets
25.89
+6.94%
24.21
-35.08%
37.30
+18.52%
31.47
Other Non Current Assets
53.46
+5.24%
50.80
+3.15%
49.25
+21.04%
40.69
Total Liabilities Net Minority Interest
1,926.68
-13.94%
2,238.70
-0.72%
2,255.03
-7.04%
2,425.71
Current Liabilities
498.86
-10.31%
556.18
+15.43%
481.84
-2.57%
494.56
Payables And Accrued Expenses
360.87
+0.65%
358.53
+16.47%
307.82
-17.46%
372.94
Payables
164.77
-0.35%
165.35
-1.29%
167.52
-28.33%
233.74
Accounts Payable
154.37
+4.29%
148.02
-1.34%
150.03
-30.51%
215.90
Current Accrued Expenses
196.10
+1.51%
193.18
+37.68%
140.31
+0.80%
139.19
Employee Benefits
—
3.83
-8.96%
4.21
-20.83%
5.31
Pensionand Other Post Retirement Benefit Plans Current
60.80
+2.28%
59.45
+46.54%
40.57
+22.26%
33.18
Total Tax Payable
10.40
-39.98%
17.33
-0.90%
17.49
-1.97%
17.84
Income Tax Payable
10.40
-39.98%
17.33
+124.63%
7.71
+24.42%
6.20
Current Debt And Capital Lease Obligation
18.75
-63.24%
51.00
-28.33%
71.16
+48.70%
47.86
Current Debt
18.75
-63.24%
51.00
+0.00%
51.00
+71.79%
29.69
Other Current Borrowings
18.75
-63.24%
51.00
+0.00%
51.00
+71.79%
29.69
Current Capital Lease Obligation
—
15.70
-22.15%
20.16
+10.96%
18.17
Current Deferred Liabilities
33.84
+11.48%
30.36
-4.05%
31.64
+2.60%
30.84
Current Deferred Revenue
33.84
+11.48%
30.36
-4.05%
31.64
+2.60%
30.84
Other Current Liabilities
—
32.91
+340.63%
7.47
+304.39%
1.85
Total Non Current Liabilities Net Minority Interest
1,427.82
-15.14%
1,682.51
-5.11%
1,773.19
-8.18%
1,931.15
Long Term Debt And Capital Lease Obligation
1,313.60
-16.60%
1,574.97
-3.54%
1,632.70
-3.19%
1,686.45
Long Term Debt
1,265.92
-17.36%
1,531.86
-2.91%
1,577.77
-2.83%
1,623.67
Long Term Capital Lease Obligation
47.68
+10.60%
43.11
-21.51%
54.93
-12.50%
62.77
Tradeand Other Payables Non Current
34.61
-1.38%
35.10
+0.11%
35.06
-16.12%
41.80
Non Current Deferred Liabilities
37.76
-22.65%
48.81
-26.55%
66.46
-53.28%
142.25
Non Current Deferred Revenue
—
9.04
-14.55%
10.59
-34.82%
16.24
Non Current Deferred Taxes Liabilities
37.76
-22.65%
48.81
-12.63%
55.87
-55.66%
126.01
Other Non Current Liabilities
41.86
+77.09%
23.64
-30.34%
33.93
-37.58%
54.35
Stockholders Equity
2,123.82
+8.07%
1,965.23
-7.45%
2,123.41
+1.60%
2,089.93
Common Stock Equity
2,123.82
+8.07%
1,965.23
-7.45%
2,123.41
+1.60%
2,089.93
Capital Stock
2.47
+0.69%
2.45
+1.57%
2.41
+0.63%
2.40
Common Stock
2.47
+0.69%
2.45
+1.57%
2.41
+0.63%
2.40
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
24.69
+0.70%
24.52
+1.55%
24.14
+0.62%
23.99
Ordinary Shares Number
24.69
+0.70%
24.52
+1.56%
24.14
+0.62%
23.99
Treasury Shares Number
0.00
-69.88%
0.00
-76.48%
0.00
+48.68%
0.00
Additional Paid In Capital
1,465.12
+3.75%
1,412.12
+3.34%
1,366.49
+2.65%
1,331.25
Retained Earnings
690.89
+0.11%
690.16
-14.57%
807.85
-3.54%
837.50
Gains Losses Not Affecting Retained Earnings
-34.63
+75.16%
-139.40
-162.62%
-53.08
+34.45%
-80.98
Treasury Stock
0.02
-76.09%
0.09
-64.89%
0.26
+7.82%
0.24
Other Equity Adjustments
-34.63
+75.16%
-139.40
-162.62%
-53.08
+34.45%
-80.98
Total Equity Gross Minority Interest
2,123.82
+8.07%
1,965.23
-7.45%
2,123.41
+1.60%
2,089.93
Total Capitalization
3,389.74
-3.07%
3,497.09
-5.51%
3,701.18
-0.33%
3,713.60
Working Capital
691.69
-21.91%
885.80
+19.79%
739.43
-0.16%
740.64
Invested Capital
3,408.49
-3.93%
3,548.09
-5.44%
3,752.18
+0.24%
3,743.29
Total Debt
1,332.35
-18.06%
1,625.97
-4.57%
1,703.86
-1.76%
1,734.30
Net Debt
976.70
-23.35%
1,274.29
-7.29%
1,374.55
-4.85%
1,444.58
Capital Lease Obligations
47.68
+10.60%
43.11
-42.59%
75.09
-7.23%
80.94
Net Tangible Assets
-9.49
+95.45%
-208.33
+5.14%
-219.62
+35.80%
-342.10
Tangible Book Value
-9.49
+95.45%
-208.33
+5.14%
-219.62
+35.80%
-342.10
Available For Sale Securities
—
—
—
0.52
Current Deferred Taxes Assets
—
5.51
-5.34%
5.82
+52.01%
3.83
Current Provisions
24.60
+2.76%
23.94
+3.28%
23.18
+193.37%
7.90
Derivative Product Liabilities
—
—
—
0.00
Financial Assets
3.81
-65.44%
11.04
+126.37%
4.88
-81.77%
26.75
Interest Payable
—
0.67
-53.39%
1.43
+38.53%
1.03
Investmentin Financial Assets
—
—
0.00
-100.00%
0.52
Investmentsin Associatesat Cost
131.59
+4231.34%
3.04
—
—
Non Current Accrued Expenses
—
0.62
-26.52%
0.84
-15.65%
1.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
179.85
-11.85%
204.03
+22.76%
166.20
+367.51%
-62.13
Cash Flow From Continuing Operating Activities
179.85
-11.85%
204.03
+22.76%
166.20
+367.51%
-62.13
Net Income From Continuing Operations
0.73
+100.62%
-117.69
-296.86%
-29.66
+60.08%
-74.29
Depreciation Amortization Depletion
200.74
-8.55%
219.51
-4.05%
228.77
-2.71%
235.15
Depreciation And Amortization
200.74
-8.55%
219.51
-4.05%
228.77
-2.71%
235.15
Other Non Cash Items
47.90
-13.50%
55.37
-7.73%
60.01
+63.25%
36.76
Stock Based Compensation
55.76
+18.93%
46.88
+15.58%
40.56
+12.60%
36.02
Provisionand Write Offof Assets
—
6.93
-69.09%
22.42
+277.57%
5.94
Operating Gains Losses
-35.24
-1497.30%
2.52
+19.58%
2.11
+4.93%
2.01
Gain Loss On Sale Of PPE
5.90
+133.94%
2.52
+19.58%
2.11
+4.93%
2.01
Change In Working Capital
-90.04
-3405.02%
-2.57
+98.11%
-135.60
+55.35%
-303.73
Change In Receivables
8.88
+118.95%
-46.84
-196.32%
48.63
+353.96%
-19.15
Changes In Account Receivables
8.88
+118.95%
-46.84
-196.32%
48.63
+353.96%
-19.15
Change In Inventory
-26.25
-255.99%
16.83
+376.84%
-6.08
+96.98%
-201.09
Change In Prepaid Assets
-10.96
-24.11%
-8.83
-175.64%
11.67
-49.04%
22.90
Change In Payables And Accrued Expense
-29.97
-190.27%
33.20
+140.11%
-82.78
-350.82%
-18.36
Change In Accrued Expense
-36.97
-278.86%
20.67
+242.74%
-14.48
+74.07%
-55.83
Change In Payable
7.00
-44.15%
12.53
+118.35%
-68.30
-282.27%
37.47
Change In Account Payable
7.00
-44.15%
12.53
+118.35%
-68.30
-282.27%
37.47
Change In Other Working Capital
-24.76
-194.39%
26.23
+131.85%
-82.36
-23.41%
-66.73
Change In Other Current Assets
-6.98
+69.85%
-23.15
+6.24%
-24.70
-15.99%
-21.29
Investing Cash Flow
122.23
+237.40%
-88.96
-1.15%
-87.95
+95.39%
-1,909.47
Cash Flow From Continuing Investing Activities
122.23
+237.40%
-88.96
-1.15%
-87.95
+95.39%
-1,909.47
Net PPE Purchase And Sale
-88.04
-10.92%
-79.37
+5.39%
-83.89
+7.11%
-90.31
Purchase Of PPE
-88.04
-10.92%
-79.37
+5.39%
-83.89
+7.11%
-90.31
Capital Expenditure
-97.02
-7.55%
-90.21
+3.70%
-93.67
+5.70%
-99.33
Net Investment Purchase And Sale
0.00
-100.00%
0.50
-88.16%
4.22
-87.22%
33.04
Purchase Of Investment
—
0.00
0.00
+100.00%
-3.40
Sale Of Investment
0.00
-100.00%
0.50
-88.16%
4.22
-88.41%
36.43
Net Business Purchase And Sale
211.19
0.00
0.00
+100.00%
-1,844.16
Purchase Of Business
—
0.00
0.00
+100.00%
-1,844.16
Gain Loss On Sale Of Business
-44.79
0.00
0.00
—
Net Intangibles Purchase And Sale
-8.97
+17.18%
-10.83
-10.80%
-9.78
-8.42%
-9.02
Purchase Of Intangibles
-8.97
+17.18%
-10.83
-10.80%
-9.78
-8.42%
-9.02
Net Other Investing Changes
8.06
+980.29%
0.75
-50.30%
1.50
+51.77%
0.99
Financing Cash Flow
-311.52
-458.29%
-55.80
-55.09%
-35.98
-102.20%
1,637.03
Cash Flow From Continuing Financing Activities
-311.52
-458.29%
-55.80
-55.09%
-35.98
-102.20%
1,637.03
Net Issuance Payments Of Debt
-304.49
-483.90%
-52.15
-70.13%
-30.65
-101.87%
1,641.31
Issuance Of Debt
0.31
0.00
0.00
-100.00%
1,664.36
Repayment Of Debt
-304.80
-484.50%
-52.15
-70.13%
-30.65
-32.95%
-23.05
Long Term Debt Issuance
0.31
0.00
0.00
-100.00%
1,664.36
Long Term Debt Payments
-304.80
-484.50%
-52.15
-70.13%
-30.65
-32.95%
-23.05
Net Long Term Debt Issuance
-304.49
-483.90%
-52.15
-70.13%
-30.65
-101.87%
1,641.31
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Proceeds From Stock Option Exercised
6.11
-44.18%
10.94
+171.98%
4.02
-54.22%
8.79
Net Other Financing Charges
-13.15
+9.91%
-14.59
-56.06%
-9.35
+28.41%
-13.06
Changes In Cash
-9.45
-115.94%
59.27
+40.21%
42.27
+112.64%
-334.56
Effect Of Exchange Rate Changes
8.85
+279.47%
-4.93
-255.83%
3.16
+133.37%
-9.48
Beginning Cash Position
308.57
+21.38%
254.22
+21.76%
208.78
-62.23%
552.83
End Cash Position
307.96
-0.20%
308.57
+21.38%
254.22
+21.76%
208.78
Free Cash Flow
82.83
-27.23%
113.83
+56.94%
72.53
+144.92%
-161.46
Interest Paid Supplemental Data
83.74
-16.02%
99.72
+3.97%
95.91
+50.54%
63.71
Income Tax Paid Supplemental Data
—
25.25
-29.48%
35.81
+30.20%
27.50
Earnings Losses From Equity Investments
1.19
0.00
0.00
—
Sale Of Business
211.19
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category